Tornike Mamuladze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tornike Mamuladze has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Kipnis
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
7 shared publications Igor Smirnov
Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, USA
6 shared publications- Antoine Drieu
Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Paris, France
4 shared publications - Taitea Dykstra
Brain Immunology and Glia (BIG) Center, Washington University in St. Louis, St. Louis, USA
4 shared publications - Jasmin Herz
Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, USA
3 shared publications - Justin Rustenhoven
Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, New Zealand
3 shared publications
Latest Publications
- 5 February 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (3) , 761
Publisher Correction: Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins
- 5 February 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (3) , 761
Publisher Correction: Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins
- Top Cited Papers
- 21 January 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (3) , 717-731
Diversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins
The choroid plexus forms a key barrier and signaling interface between the brain and peripheral circulation, yet its immune landscape remains incompletely understood. Using single-cell transcriptomics combined with lineage and spatial tracing methods, we identified three biologically distinct populations of choroid plexus macrophages, defined by differential expression of CD163, MHCII or CD9. These subsets arise from separate hematopoietic waves, occupy distinct anatomical niches and differentially rely on CSF1 and IL-34 for survival. We found that TGFβ signaling is essential to maintain their tissue-specific identities, and deletion of Tgfbr2 in these cells induces broad phenotypic reprogramming. During neuroinflammation, choroid plexus macrophages mount type I interferon responses and secrete chemokines that recruit CD8+ T cells. Finally, analysis of human choroid plexus reveals macrophage subsets corresponding to those found in mice, indicating evolutionary conservation of their molecular and immune features. Together, these findings define the developmental origin, niche specialization and immune dynamics of choroid plexus macrophages.
- 21 January 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (3) , 717-731
Top Cited PapersDiversity and immune dynamics of choroid plexus macrophages are shaped by distinct developmental origins
The choroid plexus forms a key barrier and signaling interface between the brain and peripheral circulation, yet its immune landscape remains incompletely understood. Using single-cell transcriptomics combined with lineage and spatial tracing methods, we identified three biologically distinct populations of choroid plexus macrophages, defined by differential expression of CD163, MHCII or CD9. These subsets arise from separate hematopoietic waves, occupy distinct anatomical niches and differentially rely on CSF1 and IL-34 for survival. We found that TGFβ signaling is essential to maintain their tissue-specific identities, and deletion of Tgfbr2 in these cells induces broad phenotypic reprogramming. During neuroinflammation, choroid plexus macrophages mount type I interferon responses and secrete chemokines that recruit CD8+ T cells. Finally, analysis of human choroid plexus reveals macrophage subsets corresponding to those found in mice, indicating evolutionary conservation of their molecular and immune features. Together, these findings define the developmental origin, niche specialization and immune dynamics of choroid plexus macrophages.
- 2 December 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (2)
Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by the accumulation of extracellular aggregated amyloid beta, resulting from impaired waste clearance. We recently identified new cerebrospinal fluid (CSF) efflux structures termed arachnoid cuff exit (ACE) points and speculated that these may be impacted in AD, leading to impaired waste clearance function. Using 5XFAD mice, we found progressive amyloidosis of bridging veins at ACE points. Indeed, in 5XFAD mice, there is impaired CSF efflux to the dura mater, impaired CSF flow along bridging veins, and impaired blood flow through bridging veins. These observations suggest that ACE point amyloidosis plays a role in waste clearance dysfunction in AD. In postmortem human samples, we also found striking amyloidosis of the bridging veins of individuals with AD. Moreover, in human AD specimens, there was prominent bridging vein structural degeneration, indicating advanced pathology and stronger deficits in humans. We propose that bridging vein amyloidosis is an underrecognized pathophysiological correlate of AD that may impair CSF efflux, intracranial pressure, vascular reactivity, and vascular integrity.
- 2 December 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (2)
Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by the accumulation of extracellular aggregated amyloid beta, resulting from impaired waste clearance. We recently identified new cerebrospinal fluid (CSF) efflux structures termed arachnoid cuff exit (ACE) points and speculated that these may be impacted in AD, leading to impaired waste clearance function. Using 5XFAD mice, we found progressive amyloidosis of bridging veins at ACE points. Indeed, in 5XFAD mice, there is impaired CSF efflux to the dura mater, impaired CSF flow along bridging veins, and impaired blood flow through bridging veins. These observations suggest that ACE point amyloidosis plays a role in waste clearance dysfunction in AD. In postmortem human samples, we also found striking amyloidosis of the bridging veins of individuals with AD. Moreover, in human AD specimens, there was prominent bridging vein structural degeneration, indicating advanced pathology and stronger deficits in humans. We propose that bridging vein amyloidosis is an underrecognized pathophysiological correlate of AD that may impair CSF efflux, intracranial pressure, vascular reactivity, and vascular integrity.
- Top Cited PapersOpen Access
- 9 November 2022
- Published by Springer Nature in Nature
- Vol. 611 (7936) , 585-593
Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid
Macrophages are important players in the maintenance of tissue homeostasis1. Perivascular and leptomeningeal macrophages reside near the central nervous system (CNS) parenchyma2, and their role in CNS physiology has not been sufficiently well studied. Given their continuous interaction with the cerebrospinal fluid (CSF) and strategic positioning, we refer to these cells collectively as parenchymal border macrophages (PBMs). Here we demonstrate that PBMs regulate CSF flow dynamics. We identify a subpopulation of PBMs that express high levels of CD163 and LYVE1 (scavenger receptor proteins), closely associated with the brain arterial tree, and show that LYVE1+ PBMs regulate arterial motion that drives CSF flow. Pharmacological or genetic depletion of PBMs led to accumulation of extracellular matrix proteins, obstructing CSF access to perivascular spaces and impairing CNS perfusion and clearance. Ageing-associated alterations in PBMs and impairment of CSF dynamics were restored after intracisternal injection of macrophage colony-stimulating factor. Single-nucleus RNA sequencing data obtained from patients with Alzheimer’s disease (AD) and from non-AD individuals point to changes in phagocytosis, endocytosis and interferon-γ signalling on PBMs, pathways that are corroborated in a mouse model of AD. Collectively, our results identify PBMs as new cellular regulators of CSF flow dynamics, which could be targeted pharmacologically to alleviate brain clearance deficits associated with ageing and AD.
- 9 November 2022
- Published by Springer Nature in Nature
- Vol. 611 (7936) , 585-593
Top Cited PapersOpen AccessParenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid
Macrophages are important players in the maintenance of tissue homeostasis1. Perivascular and leptomeningeal macrophages reside near the central nervous system (CNS) parenchyma2, and their role in CNS physiology has not been sufficiently well studied. Given their continuous interaction with the cerebrospinal fluid (CSF) and strategic positioning, we refer to these cells collectively as parenchymal border macrophages (PBMs). Here we demonstrate that PBMs regulate CSF flow dynamics. We identify a subpopulation of PBMs that express high levels of CD163 and LYVE1 (scavenger receptor proteins), closely associated with the brain arterial tree, and show that LYVE1+ PBMs regulate arterial motion that drives CSF flow. Pharmacological or genetic depletion of PBMs led to accumulation of extracellular matrix proteins, obstructing CSF access to perivascular spaces and impairing CNS perfusion and clearance. Ageing-associated alterations in PBMs and impairment of CSF dynamics were restored after intracisternal injection of macrophage colony-stimulating factor. Single-nucleus RNA sequencing data obtained from patients with Alzheimer’s disease (AD) and from non-AD individuals point to changes in phagocytosis, endocytosis and interferon-γ signalling on PBMs, pathways that are corroborated in a mouse model of AD. Collectively, our results identify PBMs as new cellular regulators of CSF flow dynamics, which could be targeted pharmacologically to alleviate brain clearance deficits associated with ageing and AD.
- Top Cited Papers
- 17 March 2022
- Published by Springer Nature in Nature Neuroscience
- Vol. 25 (5) , 555-560
Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels
It remains unclear how immune cells from skull bone marrow niches are recruited to the meninges. Here we report that cerebrospinal fluid (CSF) accesses skull bone marrow via dura–skull channels, and CSF proteins signal onto diverse cell types within the niches. After spinal cord injury, CSF-borne cues promote myelopoiesis and egress of myeloid cells into meninges. This reveals a mechanism of CNS-to-bone-marrow communication via CSF that regulates CNS immune responses.
- 17 March 2022
- Published by Springer Nature in Nature Neuroscience
- Vol. 25 (5) , 555-560
Top Cited PapersCerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels
It remains unclear how immune cells from skull bone marrow niches are recruited to the meninges. Here we report that cerebrospinal fluid (CSF) accesses skull bone marrow via dura–skull channels, and CSF proteins signal onto diverse cell types within the niches. After spinal cord injury, CSF-borne cues promote myelopoiesis and egress of myeloid cells into meninges. This reveals a mechanism of CNS-to-bone-marrow communication via CSF that regulates CNS immune responses.
- 1 January 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (1) , 21-22
The Sensation of Itch: From Biological Discovery to Medical Treatment
- 1 January 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (1) , 21-22
The Sensation of Itch: From Biological Discovery to Medical Treatment
- Top Cited Papers
- 3 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 373 (6553) , 409-+
Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma
Getting around the blood–brain barrier: The meninges comprise three membranes that surround and protect the central nervous system (CNS). Recent studies have noted the existence of myeloid cells resident there, but little is known about their ontogeny and function, and whether other meningeal immune cell populations have important roles remains unclear (see the Perspective by Nguyen and Kubes). Cugurra et al. found in mice that a large proportion of continuously replenished myeloid cells in the dura mater are not blood derived, but rather transit from cranial bone marrow through specialized channels. In models of CNS injury and neuroinflammation, the authors demonstrated that these myeloid cells have an immunoregulatory phenotype compared with their more inflammatory blood-derived counterparts. Similarly, Brioschi et al. show that the meninges host B cells that are also derived from skull bone marrow, mature locally, and likely acquire a tolerogenic phenotype. They further found that the brains of aging mice are infiltrated by a second population of age-associated B cells, which come from the periphery and may differentiate into autoantibody-secreting plasma cells after encountering CNS antigens. Together, these two studies may inform future treatment of neurological diseases. Science , abf7844, abf9277, this issue p. eabf7844 , p. eabf9277 ; see also abj8183, p. 396
- 3 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 373 (6553) , 409-+
Top Cited PapersSkull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma
Getting around the blood–brain barrier: The meninges comprise three membranes that surround and protect the central nervous system (CNS). Recent studies have noted the existence of myeloid cells resident there, but little is known about their ontogeny and function, and whether other meningeal immune cell populations have important roles remains unclear (see the Perspective by Nguyen and Kubes). Cugurra et al. found in mice that a large proportion of continuously replenished myeloid cells in the dura mater are not blood derived, but rather transit from cranial bone marrow through specialized channels. In models of CNS injury and neuroinflammation, the authors demonstrated that these myeloid cells have an immunoregulatory phenotype compared with their more inflammatory blood-derived counterparts. Similarly, Brioschi et al. show that the meninges host B cells that are also derived from skull bone marrow, mature locally, and likely acquire a tolerogenic phenotype. They further found that the brains of aging mice are infiltrated by a second population of age-associated B cells, which come from the periphery and may differentiate into autoantibody-secreting plasma cells after encountering CNS antigens. Together, these two studies may inform future treatment of neurological diseases. Science , abf7844, abf9277, this issue p. eabf7844 , p. eabf9277 ; see also abj8183, p. 396